Seres Therapeutics (MCRB)
NASDAQ:MCRB
Holding MCRB?
Track your performance easily

Seres Therapeutics (MCRB) Cash flow

1,010 Followers

Seres Therapeutics Cash Flow

MCRB's free cash flow for Q2 2024 was $-39.91M. For the 2024 fiscal year, MCRB's free cash flow was decreased by $113.31M and operating cash flow was $-39.81M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -181.80M$ -117.35M$ -228.82M$ 6.69M$ -93.61M$ -76.52M
Investing Cash Flow
$ -1.43M$ 10.58M$ 82.43M$ 64.09M$ -158.89M$ -30.52M
Financing Cash Flow
$ 26.63M$ 71.70M$ 129.60M$ 1.18M$ 303.42M$ 86.23M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 514.97M$ 136.15M$ 171.22M$ 188.00M$ 116.05M$ 65.13M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 16.84M$ 12.55M$ 4.93M$ 2.45M$ 2.45M$ 221.00K
Issuance Of Capital Stock
$ 1.27M$ 2.15M$ 98.49M$ 827.00K$ 268.64M$ 61.22M
Issuance Of Debt
-$ 50.52M$ 25.70M$ -948.00K$ 19.90M$ 25.00M
Repayment Of Debt
-$ -52.86M$ -1.91M$ -948.00K$ 0.00-
Free Cash Flow
$ -136.26M$ -125.33M$ -238.64M$ -2.88M$ -94.20M$ -77.52M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Seres Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis